June 15, 2018 7:58am
Volatility as stock index futures, stock index options, stock options, and single-stock futures expire
The depreciated pre-market came after U.S. indexes finished yesterday’s trading on a mixed note
Pre-open indications: 3 BUYs and 1 SELL
Out and about: Biostage (BSTG) closed up another +$0.31 to $4.51 after Wednesday’s +$0.45 to $4.20 after Tuesday’s +$0.85 to $3.75 due to its $3.60 private placement pricing on 5/31/18 following another private placement priced at $3.31 of 302,115 shares on 2/20/18. Small dollar incremental financing spread-out through multiple months solidifies the “total” control of the Chinese investors. Where is the development news to substantiate their “inflated” pricing versus their muted development progress? My OPINION, is it a pyramid scheme? Also, tell me again, why two (2) directors, one-third of their BOD, resigned? Another SAB member is overseeing her own company funded research progress and a new BOD member is supervising his hospital’s research contract – what acts of transparency are we missing – Maintaining SELL;
If you were a subscriber, you’d understand how today’s pre-open indications shed light on share pricing!
There is no breadline for share pricing and fact based intelligence!
Members only. Please login.
